The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This is a clinical Study to evaluate the effect, survival benefit and safety of
intraperitoneal docetaxel combined with oral S-1 for advanced gastric cancer with malignant
ascites.